Blue dye sentinel node mapping for early ovarian cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is testing a blue dye called Patent Blue to see if it can help surgeons find sentinel lymph nodes (the first nodes cancer might spread to) during surgery for early-stage ovarian cancer. The goal is to reduce the need for more extensive lymph node removal, possibly leading to fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a new diagnosis of suspected ovarian cancer based on MRI (O-RADS 4 or 5), which is early stage (stage I or II) on scans
- You are scheduled for a complete surgical staging procedure that includes removal of lymph nodes in the pelvis and around the aorta
- Your scans do not show any suspicious enlarged lymph nodes (≥1 cm) or spread of cancer beyond the pelvis
- You have not had previous lymph node removal, major abdominal vascular surgery, or pelvic/abdominal radiation
- You are not allergic to patent blue dye
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
This trial is testing a technique that uses a special dye to find the first lymph nodes where ovarian cancer might spread. It aims to help doctors remove only those sentinel nodes during surgery instead of removing many nodes, which could lead to fewer side effects.
This study tests a way to check for cancer spread in the lymph nodes of the pelvis during surgery for early-stage ovarian cancer. It uses a special dye and tracer to find the first lymph node that drains from the tumor.
This study tests a technique to find the first lymph nodes that might contain cancer cells during surgery for early-stage ovarian cancer. It aims to see if this method can help doctors remove fewer lymph nodes while still getting important information.
This study checks whether doctors can find the first lymph node(s) where ovarian cancer may spread using two dyes (a radioactive tracer and a green dye). It may help surgeons do more precise staging and treatment planning.
This trial studies whether taking a sample from the sentinel lymph node during surgery can help with staging early ovarian cancer. It may help doctors find spread to lymph nodes more accurately while limiting unnecessary lymph node removal in some cases.
Hear when a new Sentinel Lymph Node Biopsy (SLNB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.